ABCG2 and colorectal carcinoma: This study reveals that a novel TOX3-WDR5-H3K4me3/ABCG2 signaling axis is upregulated in colorectal cancer (CRC) stem cells; these proteins show potential as biomarkers for predicting survival of CRC patients, and targeting the pathway may help overcome the challenges of drug tolerance, recurrence and metastasis.